| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $147.5M | — | +3.6% |
| R&D Expense | $21.2M | — | +6.2% |
| SG&A Expense | $32.7M | — | +4.4% |
| Operating Income | $12.6M | — | -11.5% |
| Pre-tax Income | $7.8M | — | +439.6% |
| Income Tax | $632K | — | +23.4% |
| Net Income | $7.2M | — | +193.0% |
| EPS (Basic) | $0.04 | — | +200.0% |
| EPS (Diluted) | $0.04 | — | +200.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $129.3M | -0.3% | -12.9% |
| Accounts Receivable | $38.5M | +3.9% | +18.9% |
| Current Assets | $215.8M | +1.4% | -19.6% |
| Total Assets | $1.37B | -0.3% | -3.2% |
| Current Liabilities | $103.9M | +3.2% | -11.6% |
| Long-term Debt | $522.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $24.6M | — | -19.8% |
| Capital Expenditures | $856K | — | +73.6% |
| Investing Cash Flow | -$8.0M | — | -42.5% |
| Financing Cash Flow | -$16.4M | — | -33.5% |
| Free Cash Flow | $23.7M | — | -21.3% |
| -0.9% |
| Total Liabilities | $654.3M | -0.1% | -3.0% |
| Stockholders' Equity | $714.0M | -0.4% | -3.5% |